The optimal hemoglobin level in the cancer patientDICATO, Mario; HARPER, Peter.Seminars in oncology. 2002, Vol 29, Num 3, pp 88-91, issn 0093-7754, SUP8Article

High-dose chemotherapy in breast cancer: Where are we now?DICATO, Mario.Seminars in oncology. 2002, Vol 29, Num 3, pp 16-20, issn 0093-7754, SUP8Article

Evolving issues in oncology: what is the optimal hemoglobin level? Part oneDICATO, Mario; HARPER, Peter.Seminars in oncology. 2001, Vol 28, Num 2, issn 0093-7754, 72 p., SUP8Serial Issue

Evolving Issues in Oncology: What is the Optimal Hemoglobin Level? Part TwoDICATO, Mario; HARPER, Peter.Seminars in oncology. 2002, Vol 29, Num 3, issn 0093-7754, 94 p., SUP8Serial Issue

UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell deathJUNCKER, Tom; SCHUMACHER, Marc; DICATO, Mario et al.Biochemical pharmacology. 2009, Vol 78, Num 1, pp 1-10, issn 0006-2952, 10 p.Article

Challenges in treating hematologic malignanciesVOLIOTIS, Dimitris; DIEHL, Volker.Seminars in oncology. 2002, Vol 29, Num 3, pp 30-39, issn 0093-7754, SUP8Article

Epoetin alfa for protection of metabolic and exercise capacity in cancer patientsDANERYD, Peter.Seminars in oncology. 2002, Vol 29, Num 3, pp 69-74, issn 0093-7754, SUP8Article

The use of epoetin alfa in chemotherapy patients: A consistent profile of efficacy and safetyITRI, Loretta M.Seminars in oncology. 2002, Vol 29, Num 3, pp 81-87, issn 0093-7754, SUP8Article

The erythropoietin receptorMULCAHY, Linda.Seminars in oncology. 2001, Vol 28, Num 2, pp 19-23, issn 0093-7754, SUP8Article

The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapyDUNST, Jürgen.Seminars in oncology. 2001, Vol 28, Num 2, pp 42-48, issn 0093-7754, SUP8Article

Marine natural products as targeted modulators of the transcription factor NF-κBFOLMER, Florence; JASPARS, Marcel; DICATO, Mario et al.Biochemical pharmacology. 2008, Vol 75, Num 3, pp 603-617, issn 0006-2952, 15 p.Article

Symptomatology of anemiaLUDWIG, Heinz; STRASSER, Kathrin.Seminars in oncology. 2001, Vol 28, Num 2, pp 7-14, issn 0093-7754, SUP8Article

The effect of hemoglobin level on radiotherapy outcomes : the Canadian experienceTHOMAS, Gillian.Seminars in oncology. 2001, Vol 28, Num 2, pp 60-65, issn 0093-7754, SUP8Article

Perspectives in colorectal cancerDICATO, Mario; VAN CUTSEM, Eric; WILS, Jacques et al.Seminars in oncology. 2000, Vol 27, Num 5, issn 0093-7754, 154 p., SUP10Conference Proceedings

Curcumin as a regulator of epigenetic events : Curcumin: Recent Insights, Novel Developments, New ChallengesTEITEN, Marie-Hélène; DICATO, Mario; DIEDERICH, Marc et al.Molecular nutrition & food research (Print). 2013, Vol 57, Num 9, pp 1619-1629, issn 1613-4125, 11 p.Article

Molecular and Therapeutic Potential and Toxicity of Yalproic AcidCHATEAUVIEUX, Sébastien; MORCEAU, Franck; DICATO, Mario et al.Journal of Biomedicine and Biotechnology (Print). 2010, Vol 2010, issn 1110-7243, 479364.1-479364.18, 3Article

Current clinical practices for ovarian cancersHARPER, Peter.Seminars in oncology. 2002, Vol 29, Num 3, pp 3-6, issn 0093-7754, SUP8Article

Anemia and epoetin alfa in high-dose chemotherapy programs for breast cancer patientsDANOVA, Marco; FERRARI, Silvia.Seminars in oncology. 2002, Vol 29, Num 3, pp 21-25, issn 0093-7754, SUP8Article

Anemia of hematologic malignancies: What are the treatment options?LUDWIG, Heinz.Seminars in oncology. 2002, Vol 29, Num 3, pp 45-54, issn 0093-7754, SUP8Article

The impact of anemia and its treatment on patients with gynecologic malignanciesCAMPOS, Susana.Seminars in oncology. 2002, Vol 29, Num 3, pp 7-12, issn 0093-7754, SUP8Article

The Italian gynecological consensus statement on the use of epoetin alfa in the management of anemiaPECORELLI, Sergio.Seminars in oncology. 2002, Vol 29, Num 3, pp 13-15, issn 0093-7754, SUP8Article

The effects of anemia in hematologic malignancies: More than a symptomLITTLEWOOD, Timothy; MANDELLI, Franco.Seminars in oncology. 2002, Vol 29, Num 3, pp 40-44, issn 0093-7754, SUP8Article

Biological consequences of tumor hypoxiaHÖCKEL, Michael; VAUPEL, Peter.Seminars in oncology. 2001, Vol 28, Num 2, pp 36-41, issn 0093-7754, SUP8Article

The impact of hemoglobin levels on treatment outcomes in patients with cancerLITTLEWOOD, Timothy J.Seminars in oncology. 2001, Vol 28, Num 2, pp 49-53, issn 0093-7754, SUP8Article

New treatment approaches for lung cancer and impact on survivalCORTES-FUNES, Hernan.Seminars in oncology. 2002, Vol 29, Num 3, pp 26-29, issn 0093-7754, SUP8Article